: Marsh and McLennan upgraded to neutral from underperform at BofA Securities
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Consolidated Edison upgraded to buy from neutral at BofA Securities
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: RedHill Biopharma gets U.S. government funding for development of treatment for gastrointestinal acute radiation syndrome
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Western Alliance stock price target raised to $60 from $50 at Truist
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Intuitive Surgical stock price target raised to $375 from $315 at Stifel
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: NXP Semiconductor stock price target raised to $245 from $205 at Oppenheimer
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Lexaria Bioscience started at buy with $2 stock price target at Maxim Group
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: American Express Q2 EPS $2.89 vs. $2.57; FactSet consensus $2.81
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Knight-Swift downgraded to in line from outperform at Evercore ISI
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: NeurAxis upsizes planned IPO and lowers price
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.